chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever of 100.7 degrees; no apetite; lethargic; This case was reported by a consumer via call center representative and described the occurrence of fever in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, appetite absent and lethargy. On an unknown date, the outcome of the fever, appetite absent and lethargy were recovered/resolved.   It was unknown if the reporter considered the fever, appetite absent and lethargy to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received her 1st dose of Shingrix and experienced a fever of 100.7 degrees. The reporter did not consent to follow up. The outcome of events was reported as recovered/resolved with sequel, but in database it was mentioned as recovered/resolved, so kept as reported in database.      Lab Comments: On an unknown date lab test was performed.
Patient came in on Thursday 8/23/19 after receiving immunization and at the site of immunization she had a lump on her arm.  I told her to come back or let me know if it got worse.  She returned on Friday 8/24/19 and her upper arm was red and was hot to the touch.  Patient stated arm was hot to the touch for 2-3 days and she had a fever for 2-3 days.  Then she ended up with spots all over her body.  Everything resolved after 3 days. Upon talking with patient on the phone 9/2/19 everything is back to normal and no long term adverse reactions.
After receiving the vaccine, I sat for 15 minutes to make sure nothing happened. After that, I went home and then I started to have a headache. Then, I woke up coughing with a fever over 102 degrees. I took some Ibuprofen and Tylenol; I didn't get any better. The next morning, I was throwing up. I ended up coughing up phlegm and blood. The substance I coughed up was hard. I started taking in fluids and eating soup, but I couldn't hold anything down.  On Tuesday 10/12/2021, I went to the ER at Health Center and got diagnosed with COVID-19. The doctor told me to quarantine and then I went home. I was not able to go to work. On Wednesday 10/13/2021, I ended up back in the ER at Health Center. I ended up getting pneumonia due to having the COVID-19 virus. I ended up getting IVs put in me. The doctor gave me an oxygen odometer to take home to check my oxygen levels. They informed me if my oxygen goes below 90 then I have to go to the ER. I was prescribed Dexamethasone, 4mg tab 2xday, and Ketorolac Tromethamine 10mg, as needed, every six hours for pain. I am still currently quarantining. I did go to the doctor today and they said that they didn't hear anything abnormal with my lungs but said to finish out the rest of the 4 days of quarantining.
Information has been received from a registered nurse concerning a patient, "older than kindergarten", who was vaccinated with a varicella virus vaccine live (Oka/Merck), and subsequently experienced "a similar experience", of red, swollen spots, some up to the size of a fist at injection site. No lot numbers were provided. No further information was provided. This is one of several reports received from the same source. Additional information has been requested.
all the usual fever, aches, chills and shakes two days following; but the unusual symptom that came two days following was incredibly enlarged left supraclavicular lymph node that is very visibly swollen and very painful
Felt nauseated afteR Receiving vaccination. Did not eat or drink afteRwards. Stated had small emesis. Found on flooR in Bathroom with walker on top of heR 1230 AM 2/14/2021. Stated had lost consciousness. Side effects are as described to attending nurse.
Local redness unresolved 5 days after injection, initial swelling/warmth resolved within 3 days.
This spontaneous report as received from a pharmacist refers to multiple unspecified patients who on 04-FEB-2013 were vaccinated with doses of GARDASIL (from lot # H017698, expiry on 02-JUL-2015) or M-M-R II (from either lot# 0425AE, expiry on 27-FEB-2014 or from lot# 0367AE, expiry on 15-FEB-2014) that were exposed to an unsupported temperature excursion. No patient specific information was provided. It was unknown if any patients received both GARDASIL and M-M-R II. No adverse effects were reported. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Case number PHEH2014US024967, is an initial spontaneous report from a nurse received on 09 DEC 2014. This report refers to a 32 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN 2014/2015 (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 OCT 2014. The  nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 OCT 2014 and the temperature was between 46 to 49 degree F during the excursion.
This spontaneous report as received from a pharmacist refers to a 68 year old female patient. On 18-JAN-2014 the patient was vaccinated subcutaneous with 0.65 ml dose of ZOSTAVAX (lot # J011212, 29_AUG-2014). The pharmacist reported that the patient experienced a rash, described as redness, swelling, and about the size of the palm of a hand, at injection site, after receiving ZOSTAVAX. The patient saw pharmacist on 20-JAN-2014 and rash had begun to resolve. OTC BENADRYL or hydrocortisone cream was given for the event. The patient sought medical attention by seeing the pharmacist. Additional information has been requested.
LEG PAIN AND CALLER COULD NOT BEND DOWN ALL THE WAY AND HAVING A HARD TIME GOING UP AND DOWN THE STAIRS; FATIGUE; FLU LIKE SYMPTOMS ON 16TH MARCH AND IT WAS WORSENED ON 9TH APRIL TO 11TH APRIL; This spontaneous report received from a patient concerned a 66 year old female. The patient's weight was 97 pounds, and height was 66 inches. The patient's concurrent conditions included bell's palsy on right side of face;, nonsmoker, and abstains from alcohol, and other pre-existing medical conditions included no unknown allergies no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. Concomitant medications included clonazepam for muscle relaxant for bell's palsy.  On 16-MAR-2021, the subject experienced flu like symptoms on 16th march and it was worsened on 9th april to 11th april. On 04-APR-2021, the subject experienced leg pain and caller could not bend down all the way and having a hard time going up and down the stairs. On 04-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 16th march and it was worsened on 9th april to 11th april on 12-APR-2021, and had not recovered from leg pain and caller could not bend down all the way and having a hard time going up and down the stairs, and fatigue. This report was non-serious.
In ER on 3/3/20, pt reports within the last days she has developed right arm pain which is localized primarily to right elbow and mid-humorous region. No skin changes and no history of fall. Pt presents febrile with generalized weakness and chills.  She denies any shortness of breath or sore throat denies any abdominal pain nausea vomiting or diarrhea. Denies any recent trips out of state. In the ER her temperature was 38.4 C heart rate 68 respiratory rate 16 blood pressure 144/76 then the blood pressure dropped 88/44. UA was normal, chest x-ray was normal, WBC count was elevated at 14.54 x 10^3/mcl. Creatinine was 1.26,  2 blood cultures were sent. No growth to date. Respiratory filmarray is negative. Treating for sepsis with broad spectrum antibiotics.
Patient came in for their 2nd dose of the series and the pharmacist on duty noticed that the 1st shot that was written on their card was for the updated booster. Upon reviewing the history of the scanned image and the vaccine was entered in for the correct initial series but filled out with the booster information. There is no way of knowing which shot they actually got. Their sibling also came in on the same day and received the updated booster which they were due to receive.
sweating; fast heartbeat; chills; complete exhaustion; headache; nausea; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), HEART RATE INCREASED (fast heartbeat), CHILLS (chills), FATIGUE (complete exhaustion) and HEADACHE (headache) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PREDNISONE, CALCIUM and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 08-Feb-2021, the patient experienced HYPERHIDROSIS (sweating), HEART RATE INCREASED (fast heartbeat), CHILLS (chills), FATIGUE (complete exhaustion), HEADACHE (headache) and NAUSEA (nausea). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, HYPERHIDROSIS (sweating), HEART RATE INCREASED (fast heartbeat), CHILLS (chills), FATIGUE (complete exhaustion), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided.  Concomitant medications reported were High Blood Pressure Medication
Fever; fatugue; body aches for 36 hours; swollen and itchy arm for 3 days which later resolved into swollen; swollen and itchy arm for 3 days which later resolved into swollen; swollen, red, hot, itchy, and hard palm-sized area at injection site that became a bruise after 2 weeks; swollen, red, hot, itchy, and hard palm-sized area at injection site that became a bruise after 2 weeks; swollen, red, hot, itchy, and hard palm-sized area at injection site that became a bruise after 2 weeks; swollen, red, hot, itchy, and hard palm-sized area at injection site that became a bruise after 2 weeks; swollen, red, hot, itchy, and hard palm-sized area at injection site that became a bruise after 2 weeks; swollen, red, hot, itchy, and hard palm-sized area at injection site that became a bruise after 2 weeks; This is a spontaneous report from a contactable consumer (Patient). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EW0161), dose 2 via an unspecified route of administration, administered in Arm Left on 13Apr2021 10:15 (at the age of 50-years-old) as dose 2, single for covid-19 immunization. Medical history included allergy to arthropod bite from an unknown date (fire ant allergy). Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (MINASTRIN 24 FE). cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient previously took erythromycin, amoxicillin, neosporin bacitracin neomycin sulfate polymyxin b sulfate] and experienced allergy. The patient took first dose of bnt162b2 (Lot number: EP6955), via an unspecified route of administration, administered in Arm Left on 23Mar2021 10:15 as dose 1, single for covid-19 immunization. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID-19, post vaccination. On 14Apr2021, the patient experienced Fever, fatigue, and body aches for 36 hours, swollen and itchy arm for 3 days which later resolved into swollen, red, hot, itchy, and hard palm-sized area at injection site that became a bruise after 2 weeks. The patient did not received treatment for adverse events. Outcome of events was recovered on unspecified date of Apr2021.  No follow-up attempts are needed. No further information is expected.
3 days after vaccine - (R) arm pain at injection site, difficulty moving R shoulder and elbow, malaise, face feeling hot evaluated in clinic 2 wk after vaccine. Also ER eval - discharged home.
This all took place on a Friday? No symptom for the first two hours. Around 2 in the evening I started feeling hot. About 6 in the evening, My arm started hurting I stared getting a fever I had the fever for 2 days the highest was 102.0 degrees. I was really fatigue so I slept most of the day and took Tylenol for the pain. I was told if I had a temperature to take Tylenol so I did as instructed. I also had body aches the two days I was off and then I went back to work on Monday.
Rash appeared 4 days after 2nd dose. Rash is 5 inches long and area is red and swollen.
Received Moderna vaccine at around 10:30, immediately felt a little flushed. went home after 30 minutes. At around 12:40 or so began having itching around my neck and ears, my chest and back. Took 50 mg of Benadryl per the Doctor's instructions. I noticed a dark pink bumpy rash on my chest, back, sides and ears. I was told to continue Benadryl 4 times daily. I was advised at any point if I had trouble breathing or face swelling or any distress to go immediately to urgent care. I did not experience breathing difficulty, but the rash and itching continued. I also have nausea and abdominal cramping.
Patient experienced severe abdominal cramping shortly after taking first dose.  Patient called Dr and doctor advised to d/c use.  Per spouse, patient has no interest in pursuing vaccination with IM vaccine.
Immediate dysosmia and dysgeusia; Immediate dysosmia and dysgeusia; This is a spontaneous report from a contactable other health professional (patient herself). A 47-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142, expiry date: 31Mar2021), via intramuscular route of administration in the left arm on 28Dec2020 17:00 at a single dose for covid-19 immunization. The patient was diagnosed with COVID-19 prior to vaccination. The patient had no allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. The patient experienced immediate dysosmia and dysgeusia on 28Dec2020 17:30. The events were reported as non-serious and no treatment was received for the events. The outcome of the events was unknown. The patient had not been tested for COVID-19 since the vaccination.
progressive debilitating fatigue, exercise intolerance, pSVT requiring radiofrequency ablation 6/28/2021
gave just the adjuvant; gave just the adjuvant; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number FZ7Z4, expiry date 27th January 2023) for prophylaxis.   On 20th September 2021, the patient received Shingrix. On 20th September 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter was an office manager. The reporter reported that the patient could receive just the adjuvant solution of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter did not remember which of the patient got the full dose. The reporter did not consent to follow-up.  This was 1 of 9 cases reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021209463:Same reporter. US-GLAXOSMITHKLINE-US2021209468:Same reporter. US-GLAXOSMITHKLINE-US2021209467:Same reporter. US-GLAXOSMITHKLINE-US2021209470:Same reporter. US-GLAXOSMITHKLINE-US2021209462:Same reporter. US-GLAXOSMITHKLINE-US2021209458:same reporter US-GLAXOSMITHKLINE-US2021209482:Same reporter US-GLAXOSMITHKLINE-US2021209483:Same reporter
This spontaneous report was received from a medical assistant and refers to multiple unspecified patients of unknown demographics. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients received doses of improperly stored VARIVAX (lot # K016131, expiration date: 23-SEP-2016; lot # L024252, expiration date: 30-JUN-2017; lot # L016123, expiration date: 06-MAY-2017; dose and route were not provided). The vaccine underwent temperature excursion of -13 degrees Celsius for 48 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I was protected from infection for less than 90 days after receiving the dose. I was out of work for several days and have experienced chest pain and headaches for several weeks after infection of Covid 19.
p/vax pt devel a fever which reached 102.2 5/27/99;6/26/99 exp severe chills & diarrhea;tx w/APAP;lymerix was discontinued;pt condition is ongoing;
Excessive Screaming, Arching of the Back, Discomfort, Fever, and Encephalitis.
Felt like I was slugged in the chest for about a week. Developed a fever blister/cold sore type lesion on my upper lip that still hasn't resolved completely.  I have not experienced cold sores prior to this.
Initially, first two days, site of injection was sore, but no swelling or redness.   Soreness went away and injection site could not be found. 5 days after the shot was administered,, my arm started getting sore and I felt achy.  The 6th day, symptoms got worse, achy and chills, but no fever that I am aware of.  7th day, symptoms persisted but not as bad, except that my arm had swollen up and turned red all the way to my elbow and felt  like a large hard knot.  Today, I am not as achy or chilled, but my arm is still hot, red, and swollen .  The redness is below the injection site, although the injections site looks like a little red pimple, whereas earlier, I couldn't even find it.
This case was retrieved via a search of the scientific literature on 23 January 2012. The following is verbatim from the article. "A 41-year-old male visited a local emergency department (ED) with a 2-day history of weakness, reduced exercise tolerance, night sweats, and mid-sternal, nonradiating, nonexertional, dull chest pain. The patient had regular heart sounds without murmurs or rub and no signs of congestive heart failure. ECG revealed diffuse ST segment elevations with a Troponin of 18 ng/ml. He underwent emergent cardiac catheterization for presumed ST elevation myocardial infarction revealing minimal (nonsignificant) coronary artery disease. He had received a ACAM2000 (lot number not reported) 10 days earlier; it was suspected that his symptoms were related to smallpox vaccine-related myopericarditis. He was monitored on telemetry and started on indomethacin. An echocardiogram revealed normal left ventricular ejection fraction with thick pericardium consistent with pericarditis. A cardiac magnetic resonance imaging (MRI) scan revealed patchy diffuse mid-myocardial enhancement consistent with myocarditis. His clinical condition improved in a couple of days. However, he had improved but persistent ST-segment elevations and was discharged home on indomethacin. At a 4-week cardiology clinic visit, the patient had a normal ECG and a satisfactory stress test with improvement in pericardial thickening on echo cardiography. He subsequently returned to active duty." Documents held by sender: None.
pt recvd shots Monday 28MAR94, has been running temp 104 to 102 since then, seen by MD 29MAR94;
The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 12-Apr-2022; Expired vaccine administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 12-Apr-2022) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 12-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 12-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Pharmacy received the vial on 23-Feb-2022. One staff found the expiration date as June-2022 and another staff looked up as 1-Apr-2022 as beyond use date. Vial was initially refrigerated on 4-Apr-2022 and no temperature excursion happened.  No treatment medication was reported by reporter.
5/22/21 around 3am- right leg pain, heaviness, mininal strength. I felt numbness, I could not lift leg by myself. Within 30 minutes it subsided- I could walk  5/23/21 to now.  I have been feeling sensation of numbness at the sole my feet. I can walk- it just doesn't feel right. 5/27/21- some swelling in both legs but subsided
I tested positive for COVID-19 on 5/13/22. I had a sore, scratchy throat, body aches, very tired, high fever of 102 that I was controlling with TYLENOL. I was also sweating bad and had chills. I was prescribed PAXLOVID for five days and I felt better, but I still had a deep cough. I tested negative, but still had a bad cough. I am pretty active and since COVID-19 the tops of my feet are always sore. So, it is more difficult for me to take long walks that I used to do.
Swelling, redness, tenderness within 24 hours post dose, 5" inch induration. Tx - Tylenol 1 1/2 tsp every 4-6 hours, cold compresses.
Patient was given wrong second dose.  Patient should have recieved Moderna but recieved Pfizer.  No reaction to the patient.  Patient was notified of dosage.  State notified, MD notified.
Information has been received from a licensed practical nurse referring to an adult patient of unknown age and gender. Information about the patient's concurrent conditions or medical history was not reported. No concomitant therapies were reported. On 29-DEC-2015 the patient was inadvertently administered a pediatric dose of VAQTA 25/0.55 (unit not provided) (dose, route, lot# and expiration date were not reported). No adverse effect was reported. No product quality complaint was involved. Additional information has been requested.
Pt states cool sensation to right side of face and numbness to right hand- EMS evaluated and some resolution of cool sensation to face, hand remains numb